Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.
Sánchez Cánovas M, Fernández Garay D, Gómez Martínez F, Brozos Vázquez E, Lobo de Mena M, García Adrián S, Pacheco-Barcía V, Cacho Lavin D, Martínez de Castro E, Martín Fernández de Soignie AM, Martínez E, Rúperez Blanco AB, García Escobar I, Salvador Coloma C, Blaya Boluda N, Guirao García ME, Gambín Arroniz M, Muñoz Martín AJ. Sánchez Cánovas M, et al. Among authors: garcia escobar i. Clin Transl Oncol. 2024 Jan;26(1):171-177. doi: 10.1007/s12094-023-03233-2. Epub 2023 Jun 10. Clin Transl Oncol. 2024. PMID: 37301805 Free PMC article.
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.
Pérez-Simón JA, García-Escobar I, Martinez J, Vazquez L, Caballero D, Cañizo C, Mateos MV, San Miguel JF. Pérez-Simón JA, et al. Among authors: garcia escobar i. Bone Marrow Transplant. 2004 Jan;33(2):183-7. doi: 10.1038/sj.bmt.1704335. Bone Marrow Transplant. 2004. PMID: 14647255 Clinical Trial.
The role of RANK-ligand inhibition in cancer: the story of denosumab.
Castellano D, Sepulveda JM, García-Escobar I, Rodriguez-Antolín A, Sundlöv A, Cortes-Funes H. Castellano D, et al. Among authors: garcia escobar i. Oncologist. 2011;16(2):136-45. doi: 10.1634/theoncologist.2010-0154. Epub 2011 Feb 1. Oncologist. 2011. PMID: 21285392 Free PMC article. Review.
Safety and efficacy of primary thromboprophylaxis in cancer patients.
García Escobar I, Antonio Rebollo M, García Adrián S, Rodríguez-Garzotto A, Muñoz Martín A; Cancer&Thrombosis Working Group of the Spanish Society of Medical Oncology (SEOM). García Escobar I, et al. Among authors: garcia adrian s. Clin Transl Oncol. 2017 Jan;19(1):1-11. doi: 10.1007/s12094-016-1500-6. Epub 2016 May 4. Clin Transl Oncol. 2017. PMID: 27147252 Review.
Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?
García-Escobar I, Beato-Zambrano C, Muñoz Langa J, Brozos Vázquez E, Obispo Portero B, Gutiérrez-Abad D, Muñoz Martín AJ; Cancer and Thrombosis Working Group of the Spanish Society of Medical Oncology (SEOM). García-Escobar I, et al. Clin Transl Oncol. 2018 Sep;20(9):1097-1108. doi: 10.1007/s12094-018-1835-2. Epub 2018 Feb 22. Clin Transl Oncol. 2018. PMID: 29470777 Review.
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer.
Zugazagoitia J, Biosca M, Oliveira J, Olmedo ME, Dómine M, Nadal E, Ruffinelli JC, Muñoz N, Luna AM, Hernández B, Martínez M, Gallego I, Martínez de Castro E, Font C, Calvo V, Martínez-Marín V, Corral J, Noguerón E, Mondéjar R, García Escobar I, Salvador-Coloma C, Juan Ó, Sánchez Cánovas M, Valdivia J, Ochoa MP, López Castro R, Obispo B, Pangua C, Sereno M, Fernández Franco L, Mielgo X, Calzas J, Blasco A, Aparisi F, Chara L, Grau JF, Soares M, Gómez A, Zenzola V, García-Morillo M, Cacho D, Díaz-Serrano A, Aguado C, Ponce-Aix S, González-Larriba JL, Muñoz AJ, Lora D, Paz-Ares L, Manzano A. Zugazagoitia J, et al. Among authors: garcia morillo m, garcia escobar i. Eur Respir J. 2018 May 3;51(5):1702431. doi: 10.1183/13993003.02431-2017. Print 2018 May. Eur Respir J. 2018. PMID: 29563169 Free article. No abstract available.
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).
Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, Pérez Segura P, Quintanar Verdúguez T, Salgado Fernández M. Muñoz Martín AJ, et al. Among authors: garcia escobar i. Clin Transl Oncol. 2020 Feb;22(2):171-186. doi: 10.1007/s12094-019-02263-z. Epub 2020 Jan 24. Clin Transl Oncol. 2020. PMID: 31981080
A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry.
Carmona-Bayonas A, Gómez D, Martínez de Castro E, Pérez Segura P, Muñoz Langa J, Jimenez-Fonseca P, Sánchez Cánovas M, Ortega Moran L, García Escobar I, Rupérez Blanco AB, Fernández Pérez I, Martínez de Prado P, Porta I Balanyà R, Quintanar Verduguez T, Rodríguez-Lescure Á, Muñoz A. Carmona-Bayonas A, et al. Among authors: garcia escobar i. Eur J Intern Med. 2020 Aug;78:41-49. doi: 10.1016/j.ejim.2020.05.031. Epub 2020 May 29. Eur J Intern Med. 2020. PMID: 32482596
Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence.
García-Escobar I, Brozos-Vázquez E, Gutierrez Abad D, Martínez-Marín V, Pachón V, Muñoz Martín AJ; Cancer and Thrombosis Section of the Spanish Society of Medical Oncology (SEOM). García-Escobar I, et al. Clin Transl Oncol. 2021 Jun;23(6):1034-1046. doi: 10.1007/s12094-020-02506-4. Epub 2020 Nov 18. Clin Transl Oncol. 2021. PMID: 33206333 Free PMC article. Review.
30 results